PINP as a biological response marker during teriparatide treatment for osteoporosis

Postmenopausal women with severe osteoporosis may require treatment with the bone anabolic drug teriparatide. While changes in bone mineral density (BMD) are one measure of response, BMD changes often require a minimum of one year to observe measureable changes. Biochemical markers of bone turnover...

Descripción completa

Detalles Bibliográficos
Autores principales: Krege, J. H., Lane, N. E., Harris, J. M., Miller, P. D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4134485/
https://www.ncbi.nlm.nih.gov/pubmed/24599274
http://dx.doi.org/10.1007/s00198-014-2646-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4134485/
https://www.ncbi.nlm.nih.gov/pubmed/24599274
http://dx.doi.org/10.1007/s00198-014-2646-0

Ejemplares similares